Aprea Therapeutics Announces Agreement With Md Anderson Cancer Center to Explore Apr-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (Hnscc)
Aprea Therapeutics宣佈與MD安德森癌症中心達成協議,探討Apr-1051作爲頭頸部鱗狀細胞癌(HNSCC)的潛在治療方案
Aprea Therapeutics Announces Agreement With Md Anderson Cancer Center to Explore Apr-1051 as a Potential Treatment for Head and Neck Squamous Cell Carcinoma (Hnscc)
Aprea Therapeutics宣佈與MD安德森癌症中心達成協議,探討Apr-1051作爲頭頸部鱗狀細胞癌(HNSCC)的潛在治療方案
譯文內容由第三人軟體翻譯。
評論(0)
請選擇舉報原因